AI Article Synopsis

  • Acute pulmonary embolism (PE) can lead to rapid health decline or death, making early treatment crucial.
  • A 45-year-old man with intermediate-high risk PE underwent a hybrid therapy involving surgical thrombectomy and rivaroxaban treatment.
  • This approach improved his heart function and significantly decreased the size of the clot, potentially preventing long-term complications like chronic thromboembolic pulmonary hypertension.

Article Abstract

Acute pulmonary embolism (PE) is often associated with rapid hemodynamic deterioration or death. Therefore, early therapeutic intervention is important. A 45-year-old man was diagnosed with intermediate-high risk PE, and sequential hybrid therapy consisting of surgical thrombectomy and rivaroxaban intensive therapy was administered. During the course of treatment, echocardiography revealed improvement in pulmonary artery systolic pressure, and thrombus volume analysis by computed tomography revealed a drastic reduction in the size of the thrombus. Sequential hybrid therapy for acute PE not only stabilizes hemodynamics, but may also prevent conversion to chronic thromboembolic pulmonary hypertension by sufficiently reducing the volume of the thrombus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120437PMC
http://dx.doi.org/10.1093/omcr/omad033DOI Listing

Publication Analysis

Top Keywords

sequential hybrid
12
hybrid therapy
12
acute pulmonary
8
pulmonary embolism
8
surgical thrombectomy
8
thrombectomy rivaroxaban
8
rivaroxaban intensive
8
intensive therapy
8
therapy
5
management acute
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!